TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a roundup on Oct. 25, 2026, of seven comments from clinicians and researchers on recent medical developments. The topics range from dengue outbreaks and questions about dupilumab exposure in pregnancy to menopause-related sleep, advance care planning and early psilocybin research.
MedPage Today published a seven-quote roundup on Oct. 25, 2026, gathering clinicians’ and researchers’ reactions to health stories reported during the week. The comments covered dengue outbreaks in Florida, pregnancy exposure to dupilumab, menopause-related sleep problems, advance care planning and other topics, but the roundup itself does not provide detailed study results or public-health data.
The opening quote came from Adam Waickman, a researcher at SUNY Upstate Medical University, who said, “The cat is out of the bag.” MedPage Today described his remark as referring to large dengue outbreaks in Florida and a warning about possible further spread across the United States. The brief roundup does not give case counts, locations, dates, or a forecast supporting that concern.
Several other comments focused on questions raised by medical research. Christina Chambers of the University of California San Diego called it “an open question” whether early-life exposure to dupilumab, also known by the brand name Dupixent, might affect a child’s later risk of atopic conditions. The roundup says data indicated exposure during pregnancy appeared safe, but it does not identify the study, its size, or the outcomes assessed.
The remaining comments addressed a range of clinical issues. JoAnn Manson of Harvard Medical School described as “good news for women” a meta-analysis suggesting non-hormonal menopause drugs may ease sleep disturbances. Angelo Volandes of Dartmouth Health discussed research on a video decision-support tool that increased advance-care-planning documentation among patients nearing kidney failure. And Ellen Bradley of the University of California San Francisco pointed to biological questions raised by a small trial linking psilocybin with reduced markers of systemic inflammation and mitochondrial stress in people with Parkinson’s disease.
What the Weekly Comments Highlight
The roundup offers a quick view of issues clinicians and researchers considered notable, but the quotes are not a substitute for the underlying reports. Readers should distinguish a researcher’s interpretation, a preliminary finding and an established clinical recommendation. That distinction is particularly relevant to the comments on potential dengue spread and early research involving psilocybin.
The subjects also have different kinds of public relevance. Dengue concerns involve potential infectious-disease spread, while the dupilumab discussion concerns possible long-term outcomes after exposure early in life. The menopause and advance-care-planning comments point to treatment and care decisions. The collection signals these issues merit attention; it does not establish that any single intervention changes clinical practice.
As an affiliate, we earn on qualifying purchases.
Seven Topics Behind the Quotes
MedPage Today presented the item as a brief weekly collection of “quotable quotes,” rather than a standalone study report. Its source material names seven speakers and links each remark to a topic: dengue, dupilumab exposure in pregnancy, a multiple sclerosis misdiagnosis, an exceptionally rare infant case, non-hormonal menopause drugs, advance-care-planning documentation and psilocybin research in Parkinson’s disease.
Two comments concerned unusual or potentially instructive diagnostic cases. Marisa McGinley of Cleveland Clinic said incorrect multiple sclerosis diagnoses do occur, in reference to actress Christina Applegate’s diagnosis. Lynn Sinitsky of West Hertfordshire Teaching Hospitals discussed an infant initially treated as having straightforward constipation who was later found to have a second colon. The roundup gives no further patient details or case-report information.
The seven statements differ in evidentiary scope. The source describes a meta-analysis on menopause drugs, research on a decision-support tool, and a small trial involving psilocybin. It supplies no study titles, publication details, numerical results or methods, limiting what can be concluded from the roundup alone.
““This is good news for women.””
— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School
Evidence and Details Not Included
The roundup does not provide the underlying studies, data, or full clinical context for the findings it mentions. It is not possible from the item alone to assess the number of participants, the size or duration of any effects, how outcomes were measured, or whether results have been replicated. The statement that pregnancy exposure to dupilumab appeared safe is presented in the roundup without details about the evidence or the limits of that conclusion.
It is also unclear what evidence supports the warning about dengue spread beyond Florida, including the relevant time period and geographic projections. The source gives no case totals or public-health agency guidance. The patient cases and the comments about diagnostic error are likewise summarized briefly, with no detailed medical records or additional attribution beyond the named clinicians.
The psilocybin finding is described as coming from a small trial and involving changes in biological markers. The source does not establish that those changes improved Parkinson’s symptoms or altered the course of the disease. No treatment recommendation follows from the quote alone.
Follow the Studies and Public Health Updates
The next useful step for readers is to consult the individual reports and studies behind each comment for methods, participant numbers, outcomes and limitations. For the dengue issue, updated information from relevant public-health authorities would clarify current case patterns and whether officials identify a risk of spread to other parts of the country.
For the research topics, further published data may clarify whether the findings are robust and relevant to patient care. The roundup does not announce a forthcoming study, regulatory decision or policy change, so no specific next milestone is stated. Until fuller evidence is available, the comments should be read as snapshots of discussions around the week’s medical news, not as new clinical guidance.
Key Questions
What did MedPage Today publish?
It published a seven-quote weekly roundup on Oct. 25, 2026, featuring comments from clinicians and researchers on medical stories covered that week.
Did the roundup report new dengue case numbers?
No. It referred to large outbreaks in Florida and quoted concern about possible spread, but it did not include case counts, dates, or a public-health forecast.
Does the item establish that dupilumab is safe during pregnancy?
No. It says data on exposure during pregnancy appeared safe, without providing the study details needed to assess the evidence or its limits.
Did the psilocybin trial show improvement in Parkinson’s disease?
The roundup says a small trial linked psilocybin with reduced markers of systemic inflammation and mitochondrial stress. It does not say that symptoms improved or that the disease’s course changed.
What should readers look for next?
Readers can look for the full studies and official health updates behind the comments. The roundup does not identify a scheduled announcement or a specific upcoming milestone.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
